Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, a...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2023-07-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/29/7/22-1745_article |
| _version_ | 1827918959962226688 |
|---|---|
| author | Martina Ferrari Lorenza Di Marco Alessandra Pivetti Stefania Paduano Chiara Vecchi Veronica Bernabucci Rosina Maria Critelli Simone Lasagni Monica De Maria Donatella Venturelli Monica Pecorari Giorgia Boaretto Giulia Fregni Serpini Dante Romagnoli Roberto Mantovani Giovanni Battista Ceccherelli Erica Villa |
| author_facet | Martina Ferrari Lorenza Di Marco Alessandra Pivetti Stefania Paduano Chiara Vecchi Veronica Bernabucci Rosina Maria Critelli Simone Lasagni Monica De Maria Donatella Venturelli Monica Pecorari Giorgia Boaretto Giulia Fregni Serpini Dante Romagnoli Roberto Mantovani Giovanni Battista Ceccherelli Erica Villa |
| author_sort | Martina Ferrari |
| collection | DOAJ |
| description |
We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, allergic rhinitis was associated with reduced risk for symptomatic COVID-19.
|
| first_indexed | 2024-03-13T03:50:59Z |
| format | Article |
| id | doaj.art-94ca1aed64a54d1384cd41eefa25481a |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-03-13T03:50:59Z |
| publishDate | 2023-07-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-94ca1aed64a54d1384cd41eefa25481a2023-06-22T13:43:37ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-07-012971479148110.3201/eid2907.221745Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, ItalyMartina FerrariLorenza Di MarcoAlessandra PivettiStefania PaduanoChiara VecchiVeronica BernabucciRosina Maria CritelliSimone LasagniMonica De MariaDonatella VenturelliMonica PecorariGiorgia BoarettoGiulia Fregni SerpiniDante RomagnoliRoberto MantovaniGiovanni Battista CeccherelliErica Villa We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, allergic rhinitis was associated with reduced risk for symptomatic COVID-19. https://wwwnc.cdc.gov/eid/article/29/7/22-1745_articleCOVID-19SARS-CoV-2antibodiesblood donor populationserologic analysisItaly |
| spellingShingle | Martina Ferrari Lorenza Di Marco Alessandra Pivetti Stefania Paduano Chiara Vecchi Veronica Bernabucci Rosina Maria Critelli Simone Lasagni Monica De Maria Donatella Venturelli Monica Pecorari Giorgia Boaretto Giulia Fregni Serpini Dante Romagnoli Roberto Mantovani Giovanni Battista Ceccherelli Erica Villa Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy Emerging Infectious Diseases COVID-19 SARS-CoV-2 antibodies blood donor population serologic analysis Italy |
| title | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
| title_full | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
| title_fullStr | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
| title_full_unstemmed | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
| title_short | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
| title_sort | long term sars cov 2 antibody seroprevalence in blood donors italy |
| topic | COVID-19 SARS-CoV-2 antibodies blood donor population serologic analysis Italy |
| url | https://wwwnc.cdc.gov/eid/article/29/7/22-1745_article |
| work_keys_str_mv | AT martinaferrari longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT lorenzadimarco longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT alessandrapivetti longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT stefaniapaduano longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT chiaravecchi longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT veronicabernabucci longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT rosinamariacritelli longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT simonelasagni longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT monicademaria longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT donatellaventurelli longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT monicapecorari longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT giorgiaboaretto longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT giuliafregniserpini longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT danteromagnoli longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT robertomantovani longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT giovannibattistaceccherelli longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT ericavilla longtermsarscov2antibodyseroprevalenceinblooddonorsitaly |